InnovAge (INNV) Competitors

Addus HomeCare (NASDAQ:ADUS) and InnovAge (NASDAQ:INNV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Is ADUS or INNV more profitable?

Addus HomeCare has a net margin of 6.52% compared to InnovAge's net margin of -3.75%. Addus HomeCare's return on equity of 9.23% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.52%	9.23%	6.96%
InnovAge	-3.75%	-11.91%	-5.85%

Which has more risk and volatility, ADUS or INNV?

Addus HomeCare has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of ADUS or INNV?

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 1.4% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the media prefer ADUS or INNV?

In the previous week, Addus HomeCare had 4 more articles in the media than InnovAge. MarketBeat recorded 7 mentions for Addus HomeCare and 3 mentions for InnovAge. Addus HomeCare's average media sentiment score of 0.62 beat InnovAge's score of 0.00 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer ADUS or INNV?

Addus HomeCare currently has a consensus target price of $142.57, suggesting a potential upside of 27.46%. InnovAge has a consensus target price of $5.00, suggesting a potential upside of 12.87%. Given Addus HomeCare's stronger consensus rating and higher probable upside, equities research analysts plainly believe Addus HomeCare is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
InnovAge	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Which has better valuation & earnings, ADUS or INNV?

Addus HomeCare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.21B	1.70	$73.60M	$4.43	25.25
InnovAge	$763.85M	0.78	-$21.34M	-$0.23	-19.26

Summary

Addus HomeCare beats InnovAge on 17 of the 17 factors compared between the two stocks.